07/03/2025
3:10 PM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
6:43 PM | Bios Equity Partners, LP (Filed by)
Lantern Pharma (Subject)
| Form SCHEDULE 13D/A | |
06/13/2025
6:50 PM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:57 PM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
5:06 AM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
5:01 AM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
8:53 PM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
8:55 PM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
7:55 PM | BIOS Fund I, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:56 PM | BIOS Fund II NT, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:58 PM | BIOS Fund I QP, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for LTRN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/27/2025
8:00 PM | BIOS Fund II, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:53 PM | BIOS Fund II QP, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
7:30 AM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:35 AM | Lantern Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
7:56 PM | Lantern Pharma (Filer)
| Form 10-K/A | |
11/07/2024
8:09 PM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:15 PM | KEYSER D JEFFREY (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Lantern Pharma (Issuer)
Silberstein David S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Bhatia Kishor G. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Chandru Vijay (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Lantern Pharma (Issuer)
Margrave David R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | KEYSER D JEFFREY (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Lantern Pharma (Issuer)
Maccecchini Maria-Luisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:30 PM | Lantern Pharma (Issuer)
SHARMA PANNA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free LTRN Stock Alerts